Modular Medical, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Modular Medical, Inc. (Nasdaq: MODD) on May 14, 2026. The report discloses executive compensation actions taken by the Board of Directors on the same date.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on equity incentive awards.
Material Changes
The material event reported is the grant of stock options to two Named Executive Officers under the Company's Amended and Restated 2017 Equity Incentive Plan:
- Paul DiPerna (Chairman, President, CFO, and Treasurer): Awarded 11,218 stock options.
- Kevin Schmid (Chief Operating Officer): Awarded 4,674 stock options.
Option Terms:
- Exercise Price: $3.46 per share.
- Vesting Schedule: One-third vests on May 14, 2027; the remainder vests monthly (1/24th of the remaining shares) thereafter, contingent on continued service.
- Expiration Date: May 14, 2036.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, risk factors, or discussion of contingencies. It is a standard disclosure of compensatory arrangements.
Key Facts for Investor Verification
- Verify the total number of shares authorized under the 2017 Equity Incentive Plan to assess remaining capacity for future grants.
- Confirm the current market price of MODD stock relative to the $3.46 exercise price to evaluate the intrinsic value of the awards.
- Review the full text of the Notice of Grant (Exhibit 10.1) for specific performance conditions or acceleration clauses not detailed in the summary.